Emily is an associate in the Technology Transactions Practice, within the Firm's Global M&A Group and Global IP Group. Emily has experience with a variety of transactional matters involving the development, acquisition, transfer, and licensing of intellectual property and information technology. She has represented clients in a wide range of industries, including technology, media, entertainment, oil and gas, and life sciences, among others.
Representation of HighCape Capital Acquisition Corp. (NASDAQ: CAPA), a SPAC sponsored by HighCape Capital LP, a healthcare growth equity fund, in its US$1.46 billion business combination with Quantum-Si Incorporated, a pioneer in next generation semiconductor chip-based proteomics.
Representation of Zimmer Biomet Holdings, Inc. (NYSE: and SIX: ZBH), a global medical technology leader, and ZimVie Inc. (NASDAQ: ZIMV) in the spinoff of ZimVie, Zimmer Biomet's former dental and spine businesses.